Clinical Research Notes Templates
By Dr. Zubair Khalid, DVM, MS, PhD ·
Quick Answer
- Use a clinical research note template that separates identifying information from study data to support de-identification and privacy compliance.
- Design template fields around the specific study protocol, data collection plan, and reporting guidelines selected before enrollment begins.
- A template cannot replace institutional policy, ethics board requirements, or jurisdiction-specific privacy law, so verify each field against your governing rules.
At a Glance
| Template Component | Purpose | Common Field Examples | Compliance Consideration |
|---|---|---|---|
| Header and Identification | Link notes to the correct study, participant, and visit | Study ID, participant code, visit number, date, investigator initials | Use participant codes instead of names or direct identifiers where possible |
| Clinical Observations | Capture protocol-defined measurements and findings | Vital signs, adverse events, concomitant medications, symptom assessment | Record exactly what is observed and avoid interpretation in the source note |
| Data Management Fields | Support traceability and audit readiness | Version number, date of entry, person who entered data, corrections | Corrections must preserve the original entry and show who made the change |
| Privacy and De-identification | Protect participant identity during storage and sharing | Removal of names, addresses, medical record numbers, photos with identifiable features | Follow institutional policy and applicable privacy rules for each data set |
Why Clinical Research Notes Need a Structured Template
Clinical research notes serve as the working record of what happened during a study visit, what was measured, and what decisions were made. Without a template, notes tend to vary in completeness, legibility, and organization. That variation creates problems when the data are reviewed, analyzed, or shared with other researchers.
A structured template helps you capture the same categories of information at every visit. It also makes it easier to spot missing data before a visit ends. For example, if the template lists the required vital signs, you can check each one before the participant leaves. If the template includes a field for adverse events, you will not forget to ask about new symptoms.
The National Library of Medicine Research Methods Resources gateway provides access to biomedical books and research-method references that describe how study documentation supports the research process. These references emphasize that the quality of the research record affects the quality of the study itself.
A template is not a substitute for judgment. You still need to decide what to record, how to phrase it, and when to escalate a concern. But the template removes the need to remember every field at every visit, which reduces the risk of omission.
Core Principles for Designing a Clinical Research Note Template
Separate Direct Identifiers from Study Data
The first design decision is where to put participant identification. Direct identifiers include name, address, phone number, email, medical record number, and sometimes date of birth. These should not appear in the main study data file if the goal is de-identification.
Instead, use a participant code that is assigned at enrollment. The code links the study data to the participant, but the code itself does not reveal identity. The mapping between codes and identities is stored separately and protected under institutional policy.
This separation supports the ability to share de-identified data sets with other researchers. The NIH Data Management and Sharing Policy describes expectations for managing and sharing research data, including attention to privacy and confidentiality. The policy does not dictate a specific template, but it does establish that researchers should plan for data management and sharing from the start.
Use Protocol-Specific Fields
A generic template is a starting point, not the final product. Each study protocol defines the specific measurements, time points, and procedures that must be recorded. The template should be adapted to include those fields.
For example, a study of a blood pressure intervention needs fields for systolic and diastolic blood pressure at each visit. A study of a new laboratory test needs fields for the test result, the laboratory that ran it, and the reference range. A study of a behavioral intervention may need fields for session attendance and participant-reported outcomes.
The adaptation process should happen before the first participant is enrolled. That way, the template is ready when data collection begins.
Build in Version Control
Templates change over time. A field may be added, removed, or reworded. When that happens, the old version of the template must still be identifiable. This is important because data collected with an older version may differ from data collected with a newer version.
Use a version number and a date on every template. Record what changed and why. This practice supports the integrity of the data and makes it easier to explain differences in the data set.
Make Corrections Transparent
Errors in clinical research notes are inevitable. The issue is not whether they happen but how they are handled. A correction should never erase the original entry. Instead, draw a single line through the error, write the correct value, add the date, and initial the change.
This practice is sometimes called a source-document correction. It preserves the original record and shows that the change was deliberate and documented. The template should include space for the correction date and the initials of the person making the change.
How to Design a Clinical Research Notes Template
Step 1: Review the Protocol and Data Collection Plan
Start with the study protocol. Identify every measurement, procedure, and observation that must be recorded. List the time points at which each one occurs. This list becomes the backbone of the template.
The EQUATOR Network provides reporting guidelines for many study types. These guidelines describe the items that should be reported in a study, which can help you identify the data that needs to be collected in the first place. For example, a randomized trial may have a reporting guideline that lists the baseline characteristics and outcomes that should be reported. Those items should appear in the data collection template.
Step 2: Separate the Template into Logical Sections
Organize the template into sections that match the flow of a visit. A typical structure includes:
- Participant and visit identification
- Consent confirmation
- Vital signs and measurements
- Laboratory or diagnostic results
- Adverse event assessment
- Concomitant medications
- Study procedure documentation
- Data entry and correction fields
Each section should have a clear heading and a defined set of fields. The person using the template should be able to move through the sections in the same order at every visit.
Step 3: Choose the Format
The format depends on the study setting. A paper template is useful in a clinic where electronic data entry is not available. An electronic template, such as a spreadsheet or a data entry form in a research database, is useful when data will be entered directly into a system.
The format does not change the content. The same fields should be present in both formats. The electronic format may add validation rules, such as requiring a value in a field before the form can be submitted.
Step 4: Test the Template with a Mock Visit
Before the first participant is enrolled, test the template with a mock visit. Use a hypothetical participant and walk through the entire data collection process. This test will reveal missing fields, unclear wording, and fields that are not needed.
The test should be done by the person who will actually use the template, also by the person who designed it. The user may notice practical issues that the designer did not anticipate.
Step 5: Train the Study Team
Every person who will use the template needs training. The training should cover how to fill in each field, how to handle corrections, and how to escalate a concern. The training should also cover the privacy rules that apply to the data.
The Committee on Publication Ethics Core Practices describe the responsibilities of researchers in relation to data, authorship, and peer review. These practices are relevant to the research record because the notes you create become part of the evidence base for the study.
Step 6: Review and Revise Periodically
The template should be reviewed at regular intervals during the study. If a field is consistently left blank, it may not be needed. If a field is consistently misunderstood, it may need to be reworded. If a new measurement is added to the protocol, the template must be updated.
Each revision should be documented with a new version number and a description of the change.
Records and Measurements
What to Record in the Visit Header
The visit header identifies the record. It should include the study ID, the participant code, the visit number, the visit date, and the site. It may also include the time of the visit and the name of the person who conducted the visit.
The participant code is the link to the participant, but it is not the participant's name. The code should be assigned at enrollment and used consistently throughout the study.
What to Record in the Clinical Data Section
The clinical data section contains the measurements and observations that are the substance of the study. This section should be organized by the protocol. For example:
- Vital signs: blood pressure, heart rate, temperature, respiratory rate
- Laboratory results: test name, result, unit, reference range, laboratory
- Physical examination: findings by body system
- Adverse events: description, onset date, severity, relationship to study intervention
Each field should have a clear label and a defined unit. The template should not leave room for ambiguity about what is being recorded.
What to Record in the Notes Section
The notes section is for observations that do not fit into a structured field. This may include a description of a participant's symptoms, a note about a missed visit, or a comment about a protocol deviation.
The notes section should be written in the participant's own words where possible. The note should be factual and should not include interpretation or opinion. For example, write "participant reports headache" instead of "participant seems to be in pain."
How to Handle Corrections
When a correction is needed, the original entry must remain visible. Draw a single line through the error, write the correct value, add the date, and initial the change. Do not use correction fluid or erase the original entry.
The template should include a field for the correction date and the initials of the person who made the correction. This supports the integrity of the record.
De-identification and Privacy in Clinical Research Notes
What De-identification Means
De-identification is the process of removing or altering direct identifiers so that the data cannot be linked to a specific person. The goal is to create a data set that can be shared or analyzed without revealing the identity of the participants.
The NIH Data Management and Sharing Policy describes the expectations for managing and sharing research data. The policy does not prescribe a specific de-identification method, but it does require that researchers plan for data management and sharing.
Which Fields Are Direct Identifiers
Direct identifiers include:
- Name
- Address
- Phone number
- Email address
- Social security number
- Medical record number
- Health plan number
- Account number
- Certificate or license number
- Vehicle identifier
- Device identifier
- Web URL
- Internet protocol address
- Biometric identifier
- Full-face photograph
The template should not include these fields in the main data collection form. If a direct identifier is needed for a specific purpose, it should be stored separately and protected.
How to Handle Dates
Dates are a special case. A full date of birth is a direct identifier. A date of a visit may be needed for the study record but may also be a risk if the data is shared.
One approach is to record the date of birth as a year only, or to record the age at enrollment. Another approach is to record the visit date but remove it from the data set before sharing. The approach depends on the study and the data sharing plan.
How to Handle Free-Text Notes
Free-text notes are a particular risk for de-identification. A participant may mention their name, their employer, or their home town in a note. The note may also contain information that is not relevant to the study.
The template should include a reminder to avoid direct identifiers in the notes section. The person who writes the note should be trained to use the participant code instead of the name.
How to Handle Data Sharing
The data sharing plan should describe what data will be shared, with whom, and under what conditions. The plan should also describe how the data will be de-identified before sharing.
The NIH Data Management and Sharing Policy provides the context for this planning. The policy applies to NIH-funded research, but the principles are useful for any research that involves human participants.
Common Failure Patterns in Clinical Research Notes
Missing Data
The most common failure is missing data. A field is left blank because the person who filled in the template did not know the value, did not have the value, or forgot to record it.
The template can reduce this risk by making each field visible and by requiring a value. The template can also include a field for "not done" or "not applicable" so that a blank field is not ambiguous.
Unclear or Ambiguous Entries
A second failure is an entry that cannot be interpreted. For example, a blood pressure value of "120/80" is clear, but a value of "120" is not. A note that says "patient is doing well" is not useful because it does not describe what "well" means.
The template should include units and a clear label for each field. The notes section should be written in the participant's own words.
Corrections That Erase the Original
A third failure is a correction that erases the original entry. This can happen when the person uses correction tape, erases the value, or writes over the original. This practice destroys the audit trail and makes it impossible to know what the original value was.
The template should include a clear instruction on how to make corrections. The instruction should be part of the training.
Direct Identifiers in the Data
A fourth failure is the inclusion of direct identifiers in the data. This can happen when the participant's name is written in the notes, or when the date of birth is recorded in the data section.
The template should be designed to avoid this. The header should use the participant code, and the notes section should include a reminder to avoid direct identifiers.
Version Confusion
A fifth failure is the use of multiple versions of the template at the same time. This can happen when a new version is introduced but the old version is still in use. The data from the two versions may not be comparable.
The template should have a version number and a date. The team should be trained to use only the current version.
Quality and Welfare Controls in Clinical Research Notes
Quality Control
Quality control is the process of checking the data for accuracy and completeness. The template supports quality control by making it easy to see what data is missing and what data is present.
A quality control check may be done by a second person who reviews the template after the visit. The reviewer checks that all fields are filled, that the values are within the expected range, and that the corrections are documented.
Welfare and Safety
The template should include a field for adverse events and a field for serious adverse events. The person who fills in the template should be trained to recognize the difference and to escalate a serious adverse event according to the protocol.
The template should also include a field for the participant's well-being. This may be a simple question about how the participant is feeling, or it may be a more structured assessment.
Escalation Criteria
The template should include a clear escalation path. If a value is outside the expected range, if a serious adverse event is reported, or if a protocol deviation is identified, the person who fills in the template should know who to contact and when.
The escalation path should be defined in the protocol and in the training. The template should include a field for the escalation decision and the person who was contacted.
How to Assess Your Current Template
Step 1: Review the Fields
List every field in your current template. For each field, ask whether it is needed for the study. If a field is not needed, remove it. If a field is missing, add it.
Step 2: Check the De-identification
Review the template for direct identifiers. Check the header, the data section, and the notes section. Remove any direct identifier that is not needed.
Step 3: Test the Template
Run a mock visit with the template. Check whether the fields are clear, whether the order makes sense, and whether the template is easy to use.
Step 4: Review the Version Control
Check the version number and the date on the template. Make sure that the current version is the only version in use.
Step 5: Train the Team
Review the training materials. Make sure that the team knows how to fill in the template, how to correct an error, and how to escalate a concern.
Frequently Asked Questions
What is the difference between a clinical research note and a medical record?
A clinical research note is created for the purpose of the study. It records the data that is needed for the research. A medical record is created for the purpose of patient care. The two records may overlap, but they serve different purposes. The research note should be designed to capture the study data, not to replace the medical record.
How do I de-identify a clinical research note?
De-identification is the process of removing direct identifiers from the note. Use a participant code instead of a name. Remove the date of birth and use age instead. Remove the address and other contact information. Review the free-text notes for any direct identifiers. The NIH Data Management and Sharing Policy describes the planning that is expected for data sharing.
What should I do if a participant mentions their name in a note?
If a participant mentions their name in a free-text note, the note is no longer de-identified. The note should be reviewed and the name should be removed or replaced with the participant code. The original note should be kept in a secure location, and the de-identified version should be used for the data set.
How do I handle a correction in a paper template?
Draw a single line through the original entry. Write the correct value next to it. Add the date and your initials. Do not erase the original entry. The original entry must remain visible to show that a correction was made.
How do I handle a correction in an electronic template?
The electronic template should have a correction function that preserves the original entry. The correction should be logged with the date and the person who made the correction. The electronic system should not allow the original entry to be overwritten without a record.
What is the role of reporting guidelines in template design?
Reporting guidelines describe the items that should be reported in a study. The EQUATOR Network provides a collection of reporting guidelines for different study types. These guidelines can help you identify the data that needs to be captured in the template.
How do I know which reporting guideline to use?
The choice of reporting guideline depends on the study type. A randomized trial has a different guideline than an observational study. The EQUATOR Network provides a searchable collection of guidelines. The guideline should be selected before the study begins.
What is the role of the research record in publication ethics?
The research record is the basis for the study report. The Committee on Publication Ethics Core Practices describe the expectations for data integrity, authorship, and reporting. A complete and accurate record supports the integrity of the publication.
Using the Evidence
| Source | Best use in this topic | Important limitation |
|---|---|---|
| Research Methods Resources | official guidance | Check the linked page for current local requirements |
| EQUATOR Network | official guidance | Check the linked page for current local requirements |
| Core Practices | official guidance | Check the linked page for current local requirements |
Related Articles
- Clinical Research Coordinator Resume: Tips and Templates
- Data Management Plan Template: A Practical Guide for Researchers
- The Role of the Research Ethics Committee: What Researchers Need to Know
- Clinical Research Data Management: Core Skills and Career Pathways
- Data Visualization for Biological Research: Choosing Figures That Preserve Meaning
References and Further Reading
- Research Methods Resources. National Library of Medicine.
- EQUATOR Network. EQUATOR Network.
- Core Practices. Committee on Publication Ethics.
- NIH Grants and Funding. National Institutes of Health.
- ORCID for Researchers. ORCID.
- Data Management and Sharing Policy. National Institutes of Health.
- NCBI Literature Resources. National Center for Biotechnology Information.
- PubMed. National Library of Medicine.
This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.